Pretreatments with a novel pure potassium channel blocker, Nifekalant, were effective in the electrical atrial defibrillation: a report of two cases.
Sekita
Gaku
G
Department of Cardiovascular Medicine, Japanese Red Cross Medical Center, Tokyo.
Sawaki
Daigo
D
Otani
Yoshitaka
Y
Kobayakawa
Naoshi
N
Fukushima
Kazuyuki
K
Takeuchi
Hiroaki
H
Aoyagi
Teruhiko
T
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000628:therapy*; D003131:Combined Modality Therapy; D017147:Defibrillators, Implantable; D004554:Electric Countershock; D005260:Female; D006801:Humans; D008297:Male; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D026902:Potassium Channel Blockers; D011744:Pyrimidinones; C076259:nifekalant